- Home
- CCSI vs CERS Comparison
CCSI vs CERS Comparison
Compare CCSI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- CERS
- Stock Information
- Founded
- CCSI 2021
- CERS 1991
- Country
- CCSI United States
- CERS United States
- Employees
- CCSI N/A
- CERS N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- CERS EDP Services
- Sector
- CCSI Technology
- CERS Technology
- Exchange
- CCSI Nasdaq
- CERS Nasdaq
- Market Cap
- CCSI 464.9M
- CERS 324.3M
- IPO Year
- CCSI N/A
- CERS 1997
- Fundamental
- Price
- CCSI $21.60
- CERS $1.63
- Analyst Decision
- CCSI Hold
- CERS Buy
- Analyst Count
- CCSI 5
- CERS 3
- Target Price
- CCSI $23.60
- CERS $3.17
- AVG Volume (30 Days)
- CCSI 118.6K
- CERS 1.6M
- Earning Date
- CCSI 11-07-2024
- CERS 10-31-2024
- Dividend Yield
- CCSI N/A
- CERS N/A
- EPS Growth
- CCSI 35.51
- CERS N/A
- EPS
- CCSI 4.70
- CERS N/A
- Revenue
- CCSI $353,962,000.00
- CERS $169,984,000.00
- Revenue This Year
- CCSI N/A
- CERS $15.25
- Revenue Next Year
- CCSI N/A
- CERS $10.89
- P/E Ratio
- CCSI $4.60
- CERS N/A
- Revenue Growth
- CCSI N/A
- CERS 10.79
- 52 Week Low
- CCSI $11.62
- CERS $1.21
- 52 Week High
- CCSI $28.10
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- CCSI 46.25
- CERS 37.45
- Support Level
- CCSI $21.22
- CERS $1.71
- Resistance Level
- CCSI $22.24
- CERS $1.94
- Average True Range (ATR)
- CCSI 0.73
- CERS 0.11
- MACD
- CCSI -0.11
- CERS 0.01
- Stochastic Oscillator
- CCSI 17.18
- CERS 43.59
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.